Latest left bundle branch block Stories
Cardiac resynchronization therapy plus defibrillator implantation (CRT-D) sometimes helps women with heart failure more than men, although women are less likely to receive CRT-D than men.
In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left bundle-branch block and longer QRS duration had the lowest risks of death and all-cause, cardiovascular, and heart failure readmission.
A common test that records the heart's electrical activity could predict potentially serious cardiovascular illness.
BOTHELL, Wash., Aug. 19, 2011 /PRNewswire/ -- Verathon Inc.
Mild heart failure patients with a particular condition that results in disorganized electrical activity throughout the heart benefit substantially from cardiac resynchronization therapy with defibrillator (CRTâ€“D).
NATICK, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNISÂ® CRT-D.
SILVER SPRING, Md., Sept. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for three cardiac resynchronization therapy defibrillators (CRT-D) used to treat certain heart failure patients.
SANTA CLARA, Calif., Sept.
NATICK, Massachusetts and NICE, France, June 18, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed women received a greater clinical benefit from its cardiac resynchronization therapy defibrillators (CRT-Ds) than men.
NATICK, Mass., June 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim World Congress, June 16 - 19 in Nice, France.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.